Introduction: Human chondrosarcomas (CS; a malignant cartilage-forming bone tumor)
respond poorly to chemotherapy and radiation treatment, resulting in high morbidity and …

Opinion statement Chondrosarcomas (CHS) represent a heterogeneous group of disorders
ranging from indolent, low-grade tumors to aggressive, high-grade forms. Surgical resection …

Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …

Chondrosarcomas are the most common malignant tumors of the cartilage, are seen
predominantly in adults, and have varied clinical behavior. The majority of them affect the …

Background There are limited data about the role of chemotherapy in patients with
advanced chondrosarcomas. Methods The medical charts of 180 patients with advanced …

Abstract Learning Objectives After completing this course, the reader will be able to: Classify
the chondrosarcoma subtypes. Engage in the diagnostic process of chondrosarcoma …

Background The majority of patients with chondrosarcoma of bone have an excellent overall
survival after local therapy. However, in case of unresectable locally advanced or metastatic …

Background Chondrosarcoma is a heterogeneous group of primary bone sarcoma with an
excellent overall survival after local therapy. However, the small percentage of patients who …

Opinion statement Clinical trial enrollment should be actively encouraged in all patients
diagnosed with advanced, surgically unresectable chondrosarcoma (CS) due to the lack of …

Simple Summary Chondrosarcomas develop chemoresistance to standard anticancer
drugs, making it difficult to control unresectable or metastatic chondrosarcomas. To improve …